Phase 1 dose escalation multicenter trial of pracinostat alone and in combination with azacitidine in patients with advanced hematologic malignancies - Concepedia

Concepedia

Publication | Open Access

Phase 1 dose escalation multicenter trial of pracinostat alone and in combination with azacitidine in patients with advanced hematologic malignancies

DOI Full Paper Access

55

Citations

25

References

2017

Year

Yasmin Abaza, Tapan M. Kadia, Elias Jabbour, Marina Konopleva, Gautam Borthakur, Alessandra Ferrajoli, Zeev Estrov, William G. Wierda, Ana Alfonso Piérola, Toh Han Chong,

Abstract

The results of the current study demonstrate that pracinostat is safe, with modest single-agent activity in patients with hematological malignancies. Cancer 2017;123:4851-9. © 2017 American Cancer Society.

References

	Year	Citations

Page 1